Company: NMP
Filing Date: 2025-06-27
Form Type: S-1/A
Source: 0001213900-25-059138
Chunk: 322

Company: NMP Acquisition Corp.
Filing Date: 2025-06-27
Form: S-1/A
Chunk 322
---
 founder shares issued was determined based on the expectation that the founder shares would represent 25% of the outstanding ordinary shares upon completion of this offering (excluding the representative shares and the private placement shares underlying the private placement units and any units that the initial shareholders may purchase in this offering). Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D, or otherwise subject to an exemption from the registration of the sale of securities under the Securities Act. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. On June [•], 2025, our sponsor forfeited 650,000 founder shares and the at -riskcapital investors purchased 650,000 founder shares (of which, 335,000 founder shares were purchased by the Maxim individuals and 315,000 were purchased by the third -partyinvestors) for an aggregate purchase price of approximately $[•], or approximately $[•] per share, which resulted in our sponsor owning 3,183,333 founder shares.

II-1

In addition, our sponsor and the at -riskcapital investors have committed, pursuant to written agreements, to purchase an aggregate of 170,000 private placement units for an aggregate purchase price of $1,700,000 (or 177,500 private placement units if the underwriters’ over -allotmentoption is exercised in full for an aggregate purchase price of $1,775,000). Of those private placement units (or 177,500 private placement units), our sponsor has agreed to purchase 105,000 private placement units (or 112,500 private placement units if the underwriters’ over -allotmentoption is exercised in full) and the at -riskcapital investors have agreed to purchase 65,000 private placement units (whether or not the underwriters’ over -allotmentoption is exercised in full). These purchases will take place on a private placement basis simultaneously with the completion of our initial public offering. These issuances will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid or will be paid with respect to such sales. Item 16. Exhibits and Financial Statement Schedules. (a)The following exhibits are filed as part of this Registration Statement:

| Exhibit No. |     | Description                                                                                                              |
| 1.1*        |     | Form of Underwriting Agreement